Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Braz. J. Pharm. Sci. (Online) ; 58: e19801, 2022. tab, graf
Article in English | LILACS | ID: biblio-1394060

ABSTRACT

Abstract In the recent past, drug delivery through nanoparticles is considered an effective tool to treat various diseases. Biopolymeric nanoparticles such as protein based nanoparticles have vital role as drug carrier as it is non-antigenic, and easily biodegradable. Curcumin, plant polyphenolic anticancerous compound was loaded into the casein nanoparticles by coacervation method. Particle size and surface charge of spherical casein nanoparticles as observed to be 201.4 nm and -86.9 mV. The loading efficiency of curcumin loaded casein nanoparticles was found to 85.05 %. In vitro drug release was performed at different pH (7.4 and 3.0), and the cumulative release was observed to be 24.8 and 20.13% and at different temperatures (25°C and 37°C), the cumulative release was observed to be 24.8 and 28.60 % respectively in 48 h. Curcumin release from casein nanoparticles was shown to be in a steady, and prolonged rate. The nanoparticles were observed to have an effective antimocrobial activity than curcumin in free form. The drug loaded casein nanoparticles were found to be potent particles to protect cells from hydrogen peroxide and UV light damage. The cytotoxic activity of nanoparticles on MCF7 and A549 cells were assayed and was observed to have an IC50 value of 609 and 825.2µg/ml. Cell death was observed to be through apoptosis, accompanied by DNA fragmentation.


Subject(s)
Humans , Caseins , Curcumin , Nanoparticles , Antineoplastic Agents/pharmacology , In Vitro Techniques , Apoptosis , Inhibitory Concentration 50 , Curcumin/pharmacokinetics , Drug Liberation , A549 Cells , Antineoplastic Agents/pharmacokinetics
2.
Einstein (Säo Paulo) ; 16(2): eRW4074, 2018. tab
Article in English | LILACS | ID: biblio-953158

ABSTRACT

ABSTRACT The definition of antineoplastic administration sequences can help planning of therapeutic regimens in a more rational way, and thus optimize chemotherapy effects on patients, increasing efficacy and reducing toxic effects. In this way, this study aimed to evaluate the infusion order of antineoplastic agents of the main therapeutic protocols used in the treatment of colorectal and breast cancer which are used in a tertiary hospital, identifying possible interactions dependent on the infusion sequence. For the definition of protocols adopted in the hospital, medical prescriptions were used in the period of January to March 2016 and a literature review was conducted to search for studies assessing the sequence of administering the selected regimens. The databases used were SciELO, LILACS and MEDLINE, in addition to Micromedex Solutions® and UpToDate®. A total of 19 protocols were identified for antineoplastic therapy, 11 for colorectal cancer and 8 for breast cancer. The selected articles provided evidence for administration order of 19 protocols, and three protocols did no report relevance of infusion sequence. Sequence-dependent interactions were mainly related to toxicity, pharmacokinetics and efficacy of the drug combination. The definition of the infusion sequence has a great impact on the optimization of therapy, increasing efficacy and safety of the protocols containing combined antineoplastic therapies.


RESUMO A definição de sequências de administração de antineoplásicos pode proporcionar o planejamento dos esquemas terapêuticos de forma mais racional e, assim, otimizar o efeito da quimioterapia nos pacientes, aumentando a eficácia e reduzindo o aparecimento de efeitos tóxicos. Desta forma, o objetivo deste estudo foi avaliar a ordem de infusão dos antineoplásicos constituintes dos principais protocolos terapêuticos para o tratamento dos cânceres de mama e colorretal utilizados em um hospital terciário, identificando possíveis interações dependentes da sequência de infusão. Para definição dos protocolos adotados na Instituição, foram utilizadas as prescrições no período de janeiro a março de 2016, sendo então realizada uma revisão de literatura, para buscar estudos que avaliaram a sequência de administração dos esquemas selecionados. Para tanto, as seguintes bases de dados foram utilizadas: SciELO, LILACS e MEDLINE, além das plataformas Micromedex Solutions® e UpToDate®. Foram identificados 19 protocolos para terapia antineoplásica, sendo 11 para câncer colorretal e 8 para câncer de mama. Os artigos selecionados forneceram evidências para ordem de administração de 19 protocolos, e em 3 protocolos, não foi evidenciada a relevância da sequência infusional. As interações dependentes de sequência foram principalmente relacionadas à toxicidade, farmacocinética e eficácia da combinação de fármacos. A definição da sequência infusional possui grande impacto na otimização da terapia, aumentando a eficácia e a segurança dos protocolos, contendo terapias combinadas de antineoplásicos.


Subject(s)
Humans , Female , Breast Neoplasms/drug therapy , Colorectal Neoplasms/drug therapy , Antineoplastic Agents/administration & dosage , Infusions, Intravenous , Antineoplastic Combined Chemotherapy Protocols/standards , Antineoplastic Agents/adverse effects , Antineoplastic Agents/pharmacokinetics
3.
Rev. argent. endocrinol. metab ; 54(1): 8-20, ene.-mar. 2017. graf, tab
Article in Spanish | LILACS | ID: biblio-957963

ABSTRACT

El advenimiento de la terapia con inhibidores multicinasas (IMK) representó un cambio radical en el tratamiento de pacientes con carcinoma avanzado de tiroides. Hasta la fecha, 2 fármacos se encuentran aprobados por la Asociación Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) en Argentina: sorafenib, para pacientes con carcinoma diferenciado de tiroides radiorresistente, y vandetanib, para aquellos con carcinoma medular de tiroides (enfermedad progresiva y/o sintomática). Los estudios de fase III han demostrado que estos fármacos aumentan significativamente la supervivencia libre de progresión en este grupo de pacientes. Si bien tienen una indicación precisa, su manejo requiere de un equipo multidisciplinario en contacto estrecho con un paciente involucrado en su tratamiento. Los efectos adversos de sorafenib y vandetanib son frecuentes, sin embargo, muchos de ellos disminuyen con el tiempo y la mayoría puede manejarse a menudo sin disminuir la dosis ni suspender el fármaco. El conocimiento del correcto manejo de los efectos adversos por parte del equipo tratante constituye una herramienta fundamental para poder educar al paciente y, consecuentemente, poder prevenirlos o minimizarlos, y de esta manera evitar complicaciones severas. El objetivo de esta publicación es brindar una guía para el diagnóstico y tratamiento de los efectos adversos de estos IMK y, por otro lado, presentar la iniciativa del Hospital de Clínicas de la Universidad de Buenos Aires en cuanto a la implementación de la misma.


The advent of multikinase inhibitors therapy has led to a radical change in the treatment of patients with advanced thyroid carcinoma. The ANMAT (the Argentinian regulatory health agency) has currently approved sorafenib for patients with radioiodine resistant differentiated thyroid carcinoma, and vandetanib for patients with medullary thyroid carcinoma (progressive and/or symptomatic disease). It has been demonstrated by phase III clinical trials that these drugs improve progression free survival in this group of patients. Although they have a precise indication, an interdisciplinary team in close contact with a committed patient, are required for their effective management. The adverse events of these drugs are common, but many of them may ameliorate over time, and most of them are manageable, even without the need for dose reduction or drug withdrawal. Knowledge of the correct management of the adverse events is a fundamental tool for the medical team and for the patient to prevent or minimise them, to avoid serious complications and to obtain better patient compliance. The primary objective of this article is to provide a guideline for the diagnosis and treatment of the adverse events produced by the multikinase inhibitors, and to present the initiative of the Hospital de Clinicas in order to implement these guidelines.


Subject(s)
Humans , Male , Female , Thyroid Neoplasms/drug therapy , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Patient Care Team , Thyroid Neoplasms/diagnosis , Carcinoma, Medullary/diagnosis , Carcinoma, Medullary/drug therapy , Antineoplastic Agents/pharmacokinetics
4.
Braz. j. med. biol. res ; 50(6): e6000, 2017. tab, graf
Article in English | LILACS | ID: biblio-839313

ABSTRACT

This study aimed to investigate the feasibility of the establishment of a human cancer xenograft model using samples from computed tomography (CT)-guided percutaneous biopsy. Fresh tumor tissues obtained from 10 cancer patients by CT-guided percutaneous biopsy were subcutaneously inoculated into NOD-Prkdcem26Il2rgem26Nju (NCG) mice to establish human patient-derived tumor xenograft (PDTX) models. The formation of first and second generation xenografts was observed, and tumor volume was recorded over time. Tumor tissue consistency between the PDTX model and primary tumors in patients was compared using H&E staining and immunohistochemistry. Pharmacodynamic tests of clinically used chemotherapeutic drugs were conducted on second generation xenografts, and their effects on tumor growth and body weight were observed. CT-guided percutaneous biopsy samples were successfully collected from 10 patients with advanced cancers. The PDTX model was established in mice using tumor samples obtained from 4 cancer patients, including one small cell carcinoma sample, two adenocarcinoma samples, and one squamous cell carcinoma sample. The success rate was 40%. The obtained PDTX model maintained a degree of differentiation, and morphological and structural characteristics were similar to primary tumors. The pharmacodynamic test of chemotherapeutic drugs in the PDTX model revealed a therapeutic effect on tumor growth, as expected. CT-guided percutaneous biopsy samples can be effectively used to establish a PDTX model, and test these chemotherapy regimens.


Subject(s)
Humans , Animals , Male , Female , Middle Aged , Aged , Adenocarcinoma/pathology , Disease Models, Animal , Liver Neoplasms/pathology , Lung Neoplasms/pathology , Xenograft Model Antitumor Assays/methods , Antineoplastic Agents/pharmacokinetics , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacokinetics , Feasibility Studies , Image-Guided Biopsy/methods , Mice, Inbred Strains , Organoplatinum Compounds/pharmacokinetics , Tomography, X-Ray Computed , Xenograft Model Antitumor Assays/instrumentation
5.
Braz. dent. j ; 25(6): 532-537, Nov-Dec/2014. tab, graf
Article in English | LILACS | ID: lil-732252

ABSTRACT

The aim of this study was to analyze the sorption and solubility of a nanofilled (Filtek Z350) and a midifilled (Filtek P60) resin composite in oral environment-like substances, in a simulated deep cavity. A cylindrical cavity prepared in a bovine incisor root was incrementally filled with resin composites. The obtained resin composite cylinders were cut perpendicularly to the axis to obtain 1-mm-thick discs that were divided into fifteen groups (n=5) according to depth (1, 2, 3, 4 and 5 mm) and immersion media (distilled water - DW, artificial saliva - AS and lactic acid - LA). The sorption and solubility were calculated based on ISO 4049:2000. Additionally, the degree of conversion (DC%) was calculated by FT-IR spectroscopy. Data were analyzed using multifactor analysis of variance (MANOVA) followed by Tukey's HSD post-hoc test and linear regression analysis (a=0.05). The DC% was higher for the midifilled resin composite and was negatively influenced by cavity depth (p<0.05). The nanofilled resin composite presented higher sorption and solubility than did the midifilled (p<0.05). The immersion media influenced the sorption and the solubility as follows: LA>AS>DW, (p<0.05). Both phenomena were influenced by cavity depth, with the sorption and solubility increasing from 1 to 5 mm (p<0.05). The degradation of resin composite restorations may be greater in the deepest regions of class II restorations when the composite is exposed to organic acids present in the oral biofilm (lactic acid).


O objetivo deste estudo foi analisar a absorção e a solubilidade de uma resina composta nanopartículada (Filtek Z350) e de uma híbrida (Filtek P60) em substâncias simuladoras do ambiente oral em um modelo de cavidade profunda. Uma cavidade cilíndrica, construída em uma raiz de um incisivo bovino, foi preenchida incrementalmente com as resinas compostas. Os cilindros obtidos foram seccionados perpendicularmente ao eixo para obtenção de discos com 1 mm de espessura, que foram divididos em 15 grupos (n=5) de acordo com a profundidade (1, 2, 3, 4 e 5 mm) e o meio de imersão (água destilada - AD, saliva artificial - SA e ácido lático - AL). A absorção e a solubilidade foram calculadas com base na norma ISO 4049:2000(E). Adicionalmente, o grau de conversão (GC%) foi calculado através de espectroscopia FT-IR. Os dados obtidos foram analisados usando análise de variância multifatorial, teste de Tukey HSD e análise de regressão linear (a=0,05). A resina composta híbrida apresentou o maior grau de conversão, sendo este influenciado pela profundidade da cavidade (p<0,05). A resina composta nanopartículada apresentou maiores valores de absorção e solubilidade (p<0,05). O meio de imersão influenciou a absorção e a solubilidade: AL>SA>AD (p<0,05). Ambos os fenômenos foram influenciados pela profundidade da cavidade, com os valores aumentando de 1 para 5 mm (p<0,05). A degradação de restaurações de resinas compostas pode ser maior em regiões profundas de restaurações classe II e quando o material é exposto à ácidos orgânicos produzidos pelo biofilme oral (ácido lático).


Subject(s)
Animals , Female , Rats , Antineoplastic Agents/pharmacokinetics , Colon/metabolism , Floxuridine/pharmacokinetics , Intestinal Absorption , Biological Availability , Feces/analysis , Tissue Distribution
6.
Braz. dent. j ; 25(6): 485-488, Nov-Dec/2014. tab, graf
Article in English | LILACS | ID: lil-732260

ABSTRACT

Streptococcus mutans is specifically suppressed by intensive treatment with chlorhexidine gel, but the time for recolonization and the effect on other oral bacteria are not totally clear. In this study, recolonization of mutans streptococci was evaluated in nine healthy adult volunteers, who were highly colonized with this microorganism. Stimulated saliva was collected before (baseline) and at 1, 7, 14, 21 and 28 days after application of 1% chlorhexidine gel on volunteers' teeth for two consecutive days. On each day, the gel was applied using disposable trays for 3 x 5 min with intervals of 5 min between each application. Saliva was plated on blood agar to determine total microorganisms (TM); on mitis salivarius agar to determine total streptococci (TS) and on mitis salivarius agar plus bacitracin to determine mutans streptococci (MS). Chlorhexidine was capable of reducing the counts of MS and the proportion of MS with regard to total microorganisms (%MS/TM) (p<0.05), but these values did not differ statistically from baseline (p>0.05) after 14 days for MS and 21 days for %MS/TM. The counts of TM and TS and the proportion of MS to total streptococci did not differ statistically from baseline (p>0.05) after chlorhexidine treatment. The results suggest that the effect of chlorhexidine gel treatment on suppression of mutans streptococci is limited to less than a month in highly colonized individuals.


Streptococcus mutans é especificamente suprimido pelo tratamento intensivo com clorexidina em gel, mas o tempo de recolonização e o efeito em outras bactérias orais não está totalmente claro. Nesse estudo, a recolonização de estreptococos do grupo mutans foi avaliado em nove voluntários adultos saudáveis, os quais eram altamente colonizados por esse microrganismo. Saliva estimulada foi coletada antes (baseline) e 1, 7, 14, 21 e 28 dias após a aplicação de clorexidina em gel a 1% nos dentes dos voluntários por dois dias consecutivos. Em cada dia, o gel foi aplicado utilizando moldeiras descartáveis por 3 x 5 min com intervalos de 5 min entre cada aplicação. A saliva foi inoculada em ágar sangue para determinação dos microrganismos totais (MT); em mitis salivarius ágar para determinação dos estreptococos totais (ET) e em meio mitis salivarius com bacitracina para determinar a contagem de estreptococos do grupo mutans (EGM). O tratamento com clorexidina foi capaz de reduzir as contagens de EGM e a proporção de EGM em relação aos microrganismos totais (%EGM/MT) (p<0,05), mas esses valores não diferiram estatisticamente do baseline (p>0,05) após 14 dias para EGM e 21 dias para %EGM/MT. As contagens de MT e ET e a proporção de EGM em relação a estreptococos totais não difereriram estatisticamente do baseline (p>0,05) após o tratamento com clorexidina. Os resultados sugerem que o efeito do tratamento com clorexidina em gel na supressão de estreptococos do grupo mutans é limitado a menos de um mês em indivíduos altamente colonizados. .


Subject(s)
Animals , Male , Mice , Adenocarcinoma/drug therapy , Antineoplastic Agents/pharmacokinetics , Bromodeoxyuridine/analogs & derivatives , Floxuridine/pharmacokinetics , Fluorouracil/blood , Antineoplastic Agents/blood , Antineoplastic Agents/therapeutic use , Bromodeoxyuridine/administration & dosage , Bromodeoxyuridine/blood , Bromodeoxyuridine/pharmacokinetics , Bromodeoxyuridine/therapeutic use , Chromatography, High Pressure Liquid , Drug Synergism , Floxuridine/administration & dosage , Floxuridine/blood , Floxuridine/therapeutic use , Half-Life , Neoplasm Transplantation , Spectrophotometry, Ultraviolet
7.
Rev. bras. enferm ; 67(6): 886-890, Nov-Dec/2014. tab
Article in Portuguese | LILACS, BDENF | ID: lil-732809

ABSTRACT

Objetivou-se identificar comportamentos e práticas sexuais de homens que fazem sexo com homens no contexto da vulnerabilidade ao HIV/AIDS. Estudo transversal, exploratório descritivo. Foi realizado em um local de sociabilidade gay de Fortaleza, no Estado do Ceará, entre novembro de 2010 e março de 2011, por meio de entrevista com 189 homens que fazem sexo com homens. Encontrou-se uma amostra composta, majoritariamente, por jovens, solteiros e com alto nível educacional. A história sexual demonstrou o início precoce da vida sexual, com prevalência elevada de relação sexual com parceira do sexo oposto. Houve alta frequência de testagem para o HIV. As práticas sexuais revelaram prevalência superior da realização de sexo oral e anal, bem como altos níveis de proteção no sexo anal, apesar de baixa no sexo oral. Constatou-se uma maior incorporação das práticas de prevenção em relação ao panorama nacional do início da epidemia.


The objective was to identify behaviors and sexual practices of men who have sexual relations with other men in the context of vulnerability to HIV/AIDS. This was a cross-sectional, exploratory and descriptive study. It was carried out in a gay sociability place in Fortaleza, Ceará, Brazil, between November 2010 and March 2011, through interviews with 189 men who have sex with men. The ethical aspects were respected. We found a sample consisting mostly by young, single, and highly educated men. The sexual history demonstrated the early onset of sexual activity, with a high prevalence of sexual intercourse with a partner of the opposite sex. There was also a high prevalence of HIV testing. Sexual practices revealed high prevalence of performing oral and anal sex, as well as high levels of protection in anal sex, despite the low protection in oral sex. A greater incorporation of prevention practices was found compared to the national scene in the beginning of the disease outbreak.


El objetivo fue identificar los comportamientos y las prácticas sexuales de los hombres que tienen sexo con hombres en el contexto de la vulnerabilidad al VIH/SIDA. Fue un estudio transversal, descriptivo y exploratorio. Se celebró en una sociabilidad local gay de Fortaleza, Ceará, Brasil, entre noviembre de 2010 y marzo de 2011, a través de entrevistas con 189 hombres que tienen sexo con hombres. Se encontró una muestra compuesta en su mayoría por jóvenes, solteros y con alto nivel de educación. La historia sexual demostró el inicio temprano de la actividad sexual, la alta prevalencia de relaciones sexuales con una pareja del sexo opuesto. Hubo alta prevalencia de la prueba del VIH. Las prácticas sexuales revelaron una alta prevalencia de realizar sexo oral y anal, así como altos niveles de protección en el sexo anal, a pesar de la baja protección en el sexo oral. Se encontró una mayor incorporación de las prácticas de prevención en relación con la escena nacional en el inicio de la epidemia.


Subject(s)
Animals , Female , Rats , Fluorouracil/pharmacokinetics , Liver/drug effects , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Carcinoid Tumor/drug therapy , Carcinoid Tumor/metabolism , Floxuridine/pharmacokinetics , Floxuridine/therapeutic use , Fluorouracil/analogs & derivatives , Fluorouracil/therapeutic use , Infusions, Intravenous , Liver/metabolism , Magnetic Resonance Spectroscopy , Neoplasms, Experimental/drug therapy , Rats, Inbred Strains , Tegafur/pharmacokinetics , beta-Alanine/analysis , beta-Alanine/analogs & derivatives , beta-Alanine/biosynthesis
8.
Rev. bras. enferm ; 67(6): 949-956, Nov-Dec/2014.
Article in Portuguese | LILACS, BDENF | ID: lil-732814

ABSTRACT

Estudo que teve como objetivo apreender a percepção de enfermeiros sobre o uso do computador no ambiente de trabalho hospitalar. Participaram 14 enfermeiros de um hospital público. A coleta de dados realizou-se por meio de entrevista gravada e Diário de Campo. Os dados foram analisados de acordo com a técnica Análise de Conteúdo. Das entrevistas emergiram seis categorias temáticas abordando aspectos positivos tais como: rapidez, legibilidade e exatidão das informações; maior segurança do paciente e melhorias na qualidade do cuidado. Dentre os aspectos negativos se destacaram a conduta de copiar e colar as Prescrições Médicas e de Enfermagem; falta de computadores e distanciamento do enfermeiro do paciente. Apesar das fragilidades relatadas, os enfermeiros manifestaram-se favoráveis ao uso da tecnologia computacional no trabalho e indicaramna como recurso indispensável à qualidade do cuidado.


The objective of this study was to apprehend the perception nurses have on the use of computer in the hospital environment. Took part in the study 14 nurses of a public hospital. Collection of data took place through recorded interview and Field Diary. Data was analyzed according to Content Analysis technique. Six thematic categories emerged from the interviews such as the one that approached the positive aspects: speed, legibility and accuracy of the information; patients' safety and; improvements in the quality of care. Among the negative aspects copy and paste the Medical Prescriptions and Nursing; lack of computers and the nurse distancing to the patient were highlighted. In spite of the fragilities, they were all in favor of the use of computer technology at the work and they pointed it as indispensable resource to the quality of care.


Estudio que tuvo como objetivo aprehender la percepción de enfermeros sobre el uso de la computadora en el ambiente de trabajo hospitalario. Participaron 14 enfermeros de un hospital público. La recolección de datos fue realizado por medio de entrevista grabada y Diario de Campo. Los datos fueron analizados de acuerdo con la técnica Análisis de Contenido. De las entrevistas emergieron seis categorías temáticas como aquella que abarcó los aspectos positivos tales como: rapidez, legibilidad y exactitud de las informaciones; mayor seguridad del paciente y; mejorías en la calidad del cuidado. Entre los aspectos negativos se destacaron la conducta de copiar y pegar las Prescripciones Médicas y de Enfermería; falta de computadoras y alejamiento del enfermero con el paciente. A pesar de las fragilidades, todos se manifestaron favorables al uso de la tecnología computacional en el trabajo y la señalaron como recurso indispensable a la calidad del cuidado.


Subject(s)
Humans , Female , Adult , Middle Aged , Aged , Antineoplastic Agents/adverse effects , Folic Acid Antagonists/adverse effects , Neoplasms/drug therapy , Pyrimidines/adverse effects , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Drug Administration Schedule , Drug Evaluation , Folic Acid Antagonists/administration & dosage , Folic Acid Antagonists/pharmacokinetics , Infusions, Intravenous , Pyrimidines/administration & dosage , Pyrimidines/pharmacokinetics
9.
Invest. clín ; 55(2): 185-202, jun. 2014. ilus, tab
Article in Spanish | LILACS | ID: lil-749976

ABSTRACT

Debido a la inespecificidad de los síntomas, el cáncer gástrico (CG) es diagnosticado frecuentemente en etapas avanzadas, lo que da cuenta de los altos índices de mortalidad debido a esta neoplasia a nivel mundial. El esquema de tratamiento adyuvante o neoadyuvante en los países occidentales incluye el uso de fluoropirimidinas citotóxicas y compuestos de platino formadores de aductos en el ADN. La respuesta clínica al tratamiento con estos fármacos depende principalmente de la sensibilidad del tumor, la cual a su vez está condicionada por el nivel de expresión de los blancos terapéuticos y de las enzimas de reparación del ADN. Sumado a esto, algunos polimorfismos de línea germinal en genes asociados al metabolismo y a la respuesta a estos fármacos, han mostrado asociación con respuestas pobres y con el desarrollo de eventos adversos, incluso con resultados fatales. La identificación de biomarcadores genómicos, en la forma de polimorfismos genéticos o la expresión diferencial de genes específicos asociados a la respuesta quimioterapeútica ha sido motivo de intensa investigación como base para la aplicación de la farmacogenómica en el establecimiento de una terapia farmacológica racional y personalizada del CG. Sin embargo, ante la eventual aplicación de la farmacogenómica en el ámbito clínico, es necesario establecer el valor pronóstico real de dichos biomarcadores mediante los estudios de asociación genotipo-fenotipo, así como su prevalencia en el contexto de cada población de pacientes. Estos aspectos son indispensables al evaluar la relación costo-efectividad de la introducción de los productos de la medicina genómica predictiva en el tratamiento del CG.


Gastric cancer (GC) is often diagnosed at later stages due to the lack of specificity of symptoms associated with the neoplasm, causing high mortality rates worldwide. The first line of adjuvant and neoadjuvant treatment includes cytotoxic fluoropyrimidines and platin-containing compounds which cause the formation of DNA adducts. The clinical outcome with these antineoplastic agents depends mainly on tumor sensitivity, which is conditioned by the expression level of the drug targets and the DNA-repair system enzymes. In addition, some germ line polymorphisms, in genes linked to drug metabolism and response to chemotherapy, have been associated with poor responses and the development of adverse effects, even with fatal outcomes in GC patients. The identification of genomic biomarkers, such as individual gene polymorphisms or differential expression patterns of specific genes, in a patient-by-patient context with potential clinical application is the main focus of current pharmacogenomic research, which aims at developing a rational and personalized therapy (i.e., a therapy that ensures maximum efficacy with no predictable side effects). However, because of the future application of genomic technologies in the clinical setting, it is necessary to establish the prognostic value of these genomic biomarkers with genotype-phenotype association studies and to evaluate their prevalence in the population under treatment. These issues are important for their cost-effectiveness evaluation, which determines the feasibility of using these medical genomic research products for GC treatment in the clinical setting.


Subject(s)
Humans , Antineoplastic Agents/pharmacokinetics , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Antineoplastic Agents/adverse effects , Antineoplastic Agents/classification , Biomarkers , Biological Transport/genetics , Biotransformation/genetics , Combined Modality Therapy , Drug Combinations , Deoxycytidine/adverse effects , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacokinetics , Deoxycytidine/therapeutic use , Drug Resistance, Neoplasm/genetics , Enzymes/genetics , Ethnicity/genetics , Fluorouracil/adverse effects , Fluorouracil/analogs & derivatives , Fluorouracil/pharmacokinetics , Fluorouracil/therapeutic use , Gastrectomy , Mexico , Molecular Targeted Therapy , Organoplatinum Compounds/pharmacokinetics , Oxonic Acid/pharmacokinetics , Patient Selection , Pharmacogenetics , Precision Medicine , Prodrugs/pharmacokinetics , Stomach Neoplasms/genetics , Stomach Neoplasms/surgery , Tegafur/pharmacokinetics
10.
Indian J Cancer ; 2014 Jan-Mar; 51(1): 40-44
Article in English | IMSEAR | ID: sea-154282

ABSTRACT

CONTEXT: Rigosertib, a potent, multi-kinase inhibitor that selectively induces mitotic arrest and apoptosis in cancer cells and is non-toxic to normal cells, is being developed for the treatment of solid tumors and hematological malignancies. AIMS: To determine the safety, doselimiting toxicities, and clinical activity of rigosertib administered by 2-, 4-, or 8-hour continuous IV infusion twice-a-week for 3 weeks out of a 4-week cycle in patients with advanced solid tumor or hematological malignancies; and to confirm the safety and tolerability of the recommended phase 2 dose (RPTD). SETTINGS AND DESIGN: Phase 1, open-label, dose-escalation study in men and women ≥18 years of age. MATERIALS AND METHODS: An escalation phase optimized the duration of infusion (2, 4, or 8 hours) of 3200 mg rigosertib twice-a-week for 3 weeks of a 4-week cycle; an expansion phase confirmed the maximum tolerated dose (MTD). STATISTICAL ANALYSIS USED: All data summaries were descriptive. PK parameters were estimated using compartmental analysis. RESULTS: 25 patients (16 male, 9 female, 26- 66 years, all Asian) were treated with rigosertib, 16 in the escalation phase; 9 in the expansion phase. MTD was determined to be 3200 mg as a 4-hour infusion and 2400 mg over 4 hours was declared to be the RPTD. Best response was stable disease in 5 of 14 evaluable patients, with a mean (range) of 90 (43-108) days. CONCLUSIONS: 2400 mg rigosertib as a 4-hour infusion was identified as the RPTD. Five patients achieved stable disease lasting 6-16 weeks.


Subject(s)
Adult , Aged , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Cohort Studies , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Glycine/administration & dosage , Glycine/analogs & derivatives , Glycine/pharmacokinetics , Humans , Infusions, Intravenous , Male , Maximum Tolerated Dose , Middle Aged , Neoplasm Staging , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Prognosis , Sulfones/administration & dosage , Sulfones/pharmacokinetics , Time Factors , Tissue Distribution
11.
Biol. Res ; 47: 1-7, 2014. ilus, graf
Article in English | LILACS | ID: biblio-950735

ABSTRACT

BACKGROUND: Novel, in silico-designed anticancer compounds were synthesized in our laboratory namely, 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10),15-tetraen-17-ol (ESE-15-ol) and 2-ethyl-3-O-sulphamoyl-estra-1,3,5(10)16-tetraene (ESE-16). These compounds were designed to have improved bioavailability when compared to their source compound, 2-methoxyestradiol. This theoretically would be due to their increased binding affinity to carbonic anhydrase II, present in erythrocytes. Since the novel compounds under investigation are proposed to be transported within erythrocytes bound to carbonic anhydrase II, the morphological effect which they may exert on whole blood and erythrocytes is of great significance. A secondary outcome included revision of previously reported procedures for the handling of the whole blood sample. The purpose of this study was twofold. Firstly, the ultrastructural morphology of a healthy female's erythrocytes was examined via scanning electron microscopy (SEM) after exposure to the newly in silico-designed compounds. Morphology of erythrocytes following exposure to ESE-15-ol and ESE-16 for 3 minutes and 24 hours at 22°C were described with the use of SEM. The haemolytic activity of the compounds after 24 hours exposure were also determined with the ex vivo haemolysis assay. Secondly, storage conditions of the whole blood sample were investigated by determining morphological changes after a 24 hour storage period at 22°C and 37°C. RESULTS: No significant morphological changes were observed in the erythrocyte morphology after exposure to the novel anticancer compounds. Storage of the whole blood samples at 37°C for 24 hours resulted in visible morphological stress in the erythrocytes. Erythrocytes incubated at 22°C for 24 hours showed no structural deformity or distress. CONCLUSIONS: From this research the optimal temperature for ex vivo exposure of whole blood samples to ESE-15-ol and ESE-16 for 24 hours was determined to be 22°C. Data from this study revealed the potential of these compounds to be applied to ex vivo study techniques, since no damage occurred to erythrocytes ultrastructure under these conditions. As no structural changes were observed in erythrocytes exposed to ESE-15-ol and ESE-16, further ex vivo experiments will be conducted into the potential effects of these compounds on whole blood. Optimal incubation conditions up to 24 hours for whole blood were established as a secondary outcome.


Subject(s)
Humans , Female , Middle Aged , Sulfonamides/pharmacology , Computer Simulation , Carbonic Anhydrase Inhibitors/pharmacology , Erythrocytes/drug effects , Estradiol/analogs & derivatives , Estrenes/pharmacology , Antineoplastic Agents/pharmacology , Sulfonamides/toxicity , Sulfonamides/pharmacokinetics , Temperature , Carbonic Anhydrase Inhibitors/pharmacokinetics , Biological Availability , Microscopy, Electron, Scanning , Carrier Proteins/pharmacology , Carrier Proteins/pharmacokinetics , Carbonic Anhydrase II/drug effects , Qualitative Research , Erythrocytes/ultrastructure , Estradiol/toxicity , Estradiol/pharmacology , Estradiol/pharmacokinetics , Estrenes/pharmacokinetics , Drug Discovery , Hemolysis/drug effects , Antineoplastic Agents/pharmacokinetics
12.
Indian J Dermatol Venereol Leprol ; 2013 Nov-Dec; 79(6): 759-771
Article in English | IMSEAR | ID: sea-154675

ABSTRACT

Acitretin, a synthetic retinoid has gradually replaced etretinate in today’s dermatologic practice because of its more favorable pharmacokinetics. Acitretin over the past 20 years has proven useful in a number of diffi cult-to-treat hyperkeratotic and infl ammatory dermatoses and nonmelanoma skin cancers. It is effective both as monotherapy and in combination with other drugs for hyperkeratotic disorders. It is considered to be an established second line treatment for psoriasis and exerts its effect mainly due to its antikeratinizing, antiinfl ammatory, and antiproliferative effect. Its antineoplastic properties make it a useful agent for cancer prophylaxis. Evidence-based effi cacy, side-effect profi le, and approach to the use of acitretin would be discussed in this review. In addition to its approved uses, the various off label uses will also be highlighted in this section. Since its use is limited by its teratogenic potential and other adverse effects, including mucocutaneous effects and hepatotoxicity, this review would summarize the contraindications and precautions to be exercised before prescribing acitretin.


Subject(s)
Acitretin/administration & dosage , Acitretin/pharmacokinetics , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Cell Differentiation/drug effects , Cell Differentiation/physiology , Dermatology/methods , Dermatology/trends , Humans , Keratolytic Agents/administration & dosage , Keratolytic Agents/pharmacokinetics , Precancerous Conditions/pathology , Precancerous Conditions/prevention & control , Skin Absorption/drug effects , Skin Absorption/physiology , Skin Diseases/drug therapy , Skin Diseases/pathology
13.
Article in English | IMSEAR | ID: sea-163229

ABSTRACT

1KE8 is known as a potential target for anti-cancer medication. Indoles are biologically active nitrogen heterocyclics known for broad spectrum activities. Modification of Indole ring system with selected structural descriptors has offered a high degree of stereo specificity and diversity in activity to the moiety.


Subject(s)
Antineoplastic Agents/pharmacokinetics , Binding Sites , Computer Simulation , Cyclin-Dependent Kinase 8/metabolism , Heterocyclic Compounds, 2-Ring/pharmacokinetics , Indoles/classification , Indoles/pharmacokinetics , Molecular Docking Simulation , Molecular Dynamics Simulation
14.
Article in English | IMSEAR | ID: sea-145367

ABSTRACT

Background & objectives: Derivatives of isatin are known to have cytotoxicity against human carcinoma cell lines. This compound therefore, has a potential to be used as a chemotherapeutic agent against cancer. This study was done to investigate the antioxidant and anticancer activities of isatin, extracted from flower of a folklore medicinal plant Couroupita guianensis against human promylocytic leukemia (HL60) cells. Methods: Active fractions demonstrating anticancer and antioxidant activities were isolated from the extracts of shade-dried flowers of C. guianensis by bioassay guided fractionation. The free radical scavenging activity was determined using lipid peroxidation assay. Cytotoxicity against human promylocytic leukemia HL60 cells was determined by MTT assay. Apoptotic activity was analyzed by DNA fragmentation and flowcytometry. Results: Isatin isolated from the active fraction showed antioxidant activity with the EC50 value of 72.80 μg/ml. It also exhibited cytotoxicity against human promylocytic leukemia HL60 cells in dose-dependant manner with the CC50 value of 2.94 μg/ml. The isatin-treated cells underwent apoptosis and DNA fragmentation. Apoptosis was confirmed by the FACS analysis using FITC-annexin V markers. Interpretation & conclusions: Isatin showed antioxidant activity and was cytotoxic to the HL60 cells due to induction of apoptosis. The isatin can be further evaluated to be used as a prophylactic agent to prevent the free radical-induced cancer and as a chemotherapeutic agent to kill the cancer cells.


Subject(s)
Antineoplastic Agents/pharmacokinetics , Apoptosis , Cell Line, Tumor , Cytotoxicity, Immunologic , Flowers , Free Radicals , Humans , India , Isatin/therapeutic use , Leukemia, Promyelocytic, Acute/drug therapy , Plant Extracts/pharmacology , Plants, Medicinal/therapeutic use
15.
Braz. j. pharm. sci ; 47(2): 363-371, Apr.-June 2011. ilus, tab
Article in English | LILACS | ID: lil-595824

ABSTRACT

A liquid-liquid extraction (LLE) combined with high-performance liquid chromatography-diode array detection method for simultaneous analysis of four chemically and structurally different antineoplastic drugs (cyclophosphamide, doxorubicin, 5-fluorouracil and ifosfamide) was developed. The assay was performed by isocratic elution, with a C18 column (5 µm, 250 x 4.6 mm) and mobile phase constituted by water pH 4.0- acetonitrile-methanol (68:19:13, v/v/v), which allowed satisfactory separation of the compounds of interest. LLE, with ethyl acetate, was used for sample clean-up with recoveries ranging from 60 to 98 percent. The linear ranges were from 0.5 to 100 µg mL-1, for doxorubicin and 1 to 100 µg mL-1, for the other compounds. The relative standard deviations ranged from 5.5 to 17.7 percent. This method is a fast and simple alternative that can be used, simultaneously, for the determination of the four drugs in plasma, with a range enabling quantification of the drugs in pharmacokinetics, bioequivalence and therapeutic drug-monitoring studies.


Um método de extração líquido-líquido (ELL) combinado com cromatografia líquida de alta eficiência-detector de arranjo de diodos foi desenvolvido para análise simultânea de quatro fármacos antineoplásicos quimicamente e estruturalmente diferentes (ciclofosfamida, doxorrubicina, fluoruracila e ifosfamida). O estudo foi realizado sob condições isocráticas, com coluna C18 (5µm, 250 x 4.6 mm) e fase móvel constituída por água pH 4.0-acetonitrila-metanol (68:19:13, v/v/v), que permitiu separação satisfatória dos analitos de interesse. A ELL, com acetato de etila, foi utilizada para limpeza da amostra, com recuperação variando de 60 a 98 por cento. As faixas foram lineares de 0,5 a 100 µg mL-1 para doxorrubicina e 1 a 100 µg mL-1 para os outros compostos. O desvio padrão relativo variou de 5,5 a 17,7 por cento. Este método é uma alternativa rápida e simples que pode ser usado, simultaneamente, para a determinação dos quatro fármacos em plasma, com uma faixa que permite quantificá-los em estudos de farmacocinética, bioequivalência e monitorização terapêutica.


Subject(s)
Adult , Animals , Male , Rats , Antineoplastic Agents/analysis , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/blood , Biological Assay , Drug Screening Assays, Antitumor
16.
Braz. j. med. biol. res ; 40(8): 1149-1157, Aug. 2007. ilus, graf, tab
Article in English | LILACS | ID: lil-456799

ABSTRACT

We encapsulated cisplatin into stealth pH-sensitive liposomes and studied their stability, cytotoxicity and accumulation in a human small-cell lung carcinoma cell line (GLC4) and its resistant subline (GLC4/CDDP). Since reduced cellular drug accumulation has been shown to be the main mechanism responsible for resistance in the GLC4/CDDP subline, we evaluated the ability of this new delivery system to improve cellular uptake. The liposomes were composed of dioleoylphosphatidylethanolamine (DOPE), cholesteryl hemisuccinate (CHEMS), and distearoylphosphatidylethanolamine-polyethyleneglycol 2000 (DSPE-PEG2000) and were characterized by determining the encapsulation percentage as a function of lipid concentration. Among the different formulations, DOPE/CHEMS/DSPE-PEG liposomes (lipid concentration equal to 40 mM) encapsulated cisplatin more efficiently than other concentrations of liposomes (about 20.0 percent, mean diameter of 174 nm). These liposomes presented good stability in mouse plasma which was obtained using a 0.24-M EDTA solution (70 percent cisplatin was retained inside the liposomes after 30 min of incubation). Concerning cytotoxic effects, they are more effective (1.34-fold) than free cisplatin for growth inhibition of the human lung cancer cell line A549. The study of cytotoxicity to GLC4 and GLC4/CDDP cell lines showed similar IC50 values (approximately 1.4 æM), i.e., cisplatin-resistant cells were sensitive to this cisplatin formulation. Platinum accumulation in both sensitive and resistant cell lines followed the same pattern, i.e., approximately the same intracellular platinum concentration (4.0 x 10-17 mol/cell) yielded the same cytotoxic effect. These results indicate that long-circulating pH-sensitive liposomes, also termed as stealth pH-sensitive liposomes, may present a promising delivery system for cisplatin-based cancer treatment. This liposome system proved to be able to circumvent the cisplatin resistance, whereas...


Subject(s)
Humans , Antineoplastic Agents/pharmacology , Carcinoma, Non-Small-Cell Lung/drug therapy , Cisplatin/pharmacology , Liposomes/chemistry , Lung Neoplasms/drug therapy , Antineoplastic Agents/pharmacokinetics , Cell Line, Tumor , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Cisplatin/pharmacokinetics , Drug Delivery Systems , Drug Screening Assays, Antitumor , Lung Neoplasms/metabolism , Lung Neoplasms/pathology
17.
Rev. bras. cancerol ; 49(2): 103-112, abr.-jun. 2003. tab
Article in Portuguese | LILACS | ID: lil-407504

ABSTRACT

A resistência a múltiplas drogas (MDR) é um dos principais obstáculos no tratamento quimioterápico de pacientes com câncer. O processo de resistência é multifatorial, mas o mecanismo mais bem caracterizado é a superexpressão da glicoproteína P (Pgp), uma proteína de membrana plasmática que funciona como uma bomba de efluxo levando a uma diminuição da concentração intracelular do quimioterápico. A circunvenção da resistência pode ser obtida utilizando-se agentes reversores capazes de inibir a atividade funcional da Pgp e de outras bombas de efluxorelacionadas. Nesta revisão, discutimos o uso do imunossupressor Ciclosporina A (CSA) e de seus análogos como agentes reversores da MDR. Aspectos como sua combinação com ciclofilinas, sua capacidade de inibir a atividade funcional da Pgp e seu uso clínico, especialmente em leucemias, são discutidos baseados tanto na literatura quanto em resultados dos próprios autores.


Subject(s)
Humans , Male , Female , Antineoplastic Agents/pharmacokinetics , Cyclosporine , ATP Binding Cassette Transporter, Subfamily B, Member 1/administration & dosage , ATP Binding Cassette Transporter, Subfamily B, Member 1/therapeutic use , Immunosuppressive Agents , Drug Resistance, Multiple , Leukemia
18.
J. Health Sci. Inst ; 20(2): 103-115, jul.-dez. 2002.
Article in Portuguese, English | LILACS | ID: lil-359929

ABSTRACT

Produtos naturais são uma das principais fontes de novos fármacos antineoplásicos. Plantas terrestres forneceram os alcalóides da vinca, o paclitaxel e a camptotecina, hoje encontrados no mercado, e continuam a fornecer novos compostos antineoplásicos, em especial, as plantas tropicais. Os organismos marinhos são produtores de um grande número de novos protótipos, alguns já sendo avaliados em fases clínicas. A tecnologia envolvida no entendimento dos processos bioquímicas angiogênicos e apoptóticos tem auxiliado na identificação de novas moléculas-alvo, e tem um papel decisivo na identificação de novas drogas antineoplásicas. O Brasil, sendo o país que possui a mais alta biodiversidade, em termos de organismos vegetais e animais, está na posição de ser um dos líderes na pesquisa de produtos naturais.


Subject(s)
Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/therapeutic use , Apoptosis , Ecosystem , Biological Factors/pharmacokinetics , Neoplasms , Vinblastine , Vincristine , Brazil
20.
J. bras. med ; 81(1): 79-88, jul. 2001.
Article in Portuguese | LILACS | ID: lil-296404

ABSTRACT

A soja é um vegetal com altíssimo valor nutritivo e que além de apresentar uma estrutura protéica completa também possui isoflavonas, substâncias com propriedades estrogen-like. Estes componentes presentes na soja produzem efeitos clínicos que são benéficos tanto na prevenção quanto no tratamento de diversas patologias, como o câncer, doenças cardiovasculares, osteoporose e outras, desde que usados regularmente. Para isso há uma variedade de produtos à base de soja, que devem ser utilizados tanto pelo seu valor nutritivo quanto terapêutico


Subject(s)
Humans , Anticarcinogenic Agents/pharmacokinetics , Antineoplastic Agents/pharmacokinetics , Diabetes Mellitus/therapy , Cardiovascular Diseases/prevention & control , Soybeans/therapeutic use , Genistein/therapeutic use , Isoflavones/therapeutic use , Nutritive Value , Osteoporosis/prevention & control , Climacteric , Herbal Medicine , Soybean Proteins
SELECTION OF CITATIONS
SEARCH DETAIL